Novo Nordisk invests €726m on API manufacturing
The capital will be used to extend existing facilities, as well as building out an entirely new plant.
Archives for November 29, 2022
FDA CRL on cancer treatment sees Spectrum shed 75% of R&D staff
The company stated they were ‘not surprised’ by the US FDA’s decision, and immediately reacted by de-prioritizing development of poziotinib.
J&J’s ketamine nasal spray outperforms traditional depression treatment
A study pitted Spravato against quetiapine extended-release, with the results showing that J&J’s product was more effective in patients with treatment-resistant major depressive disorder.